Back to Newsroom

inne Presents Preclinical Calcium and Kidtal Research at FAT 2026 in Rome

The women’s health company shares new preclinical findings on calcium monitoring and Kidtal® research at the Rome conference.

News provided by
inne
September 23, 2026
12:42 pm
EDT
Dr. Emily Zhou, Head of R&D for Asia Pacific at inne, presents research involving Kidtal® at FAT 2026 in Rome. / Source: inne (EZ Newswire)
Dr. Emily Zhou presents bone research at FAT 2026 in Rome. / Source: inne (EZ Newswire)
Dr. Emily Zhou discusses nutrition research findings with a fellow scholar. / Source: inne (EZ Newswire)
inne Kidtal® Liquid Calcium. / Source: inne (EZ Newswire)

ROME, Italy, September 23, 2026 (EZ Newswire) -- German nutrition brand inne presented preclinical research involving calcium supplementation combined with Kidtal®, its proprietary bamboo-derived ingredient, at the 8th Euro-Global Conference on Food Science and Technology (FAT 2026), held Sept. 14–16 in Rome.

Dr. Emily Zhou, Head of R&D for Asia Pacific at inne, delivered an oral presentation on the effects of calcium supplementation combined with Kidtal® on longitudinal bone growth in a calcium-deficient adolescent rat model. The presentation examined findings related to bone length, bone microstructure, growth plate development, insulin-like growth factor 1 (IGF-1) and calcium absorption.

The underlying study was published in the peer-reviewed journal Nutrients in June 2025 under the title “Calcium Supplement Combined with Dietary Supplement Kidtal Can Promote Longitudinal Growth of Long Bone in Calcium-Deficient Adolescent Rats.”

The findings remain preclinical and should not be interpreted as evidence of growth-related benefits in humans. inne said the results will inform further research on Kidtal®, including clinical research designed to evaluate its effects in human populations.

“Children’s growth is influenced by multiple biological, nutritional and environmental factors, which makes careful, multidisciplinary research essential,” Zhou said. “Presenting this work in Rome gave us an opportunity to exchange perspectives with researchers from different scientific backgrounds. These discussions will help inform our future research, including studies that consider the dietary patterns and nutritional needs of children in different regions.”

The presentation forms part of inne’s broader research program in children’s nutrition. Originating in Germany, the brand is expanding its research across different markets, with an emphasis on developing evidence that reflects local dietary habits, lifestyles and population characteristics.

inne plans to advance clinical research on Kidtal® to evaluate its potential effects using a broader range of clinical measures, Zhou said.

About inne

inne is a German nutrition brand developing science-based nutritional solutions for people at different stages of life, with particular expertise in children’s nutrition. Supported by a global R&D network spanning Germany, China and the United States, inne develops products across healthy growth, immune health, eye and brain nutrition, women’s health, and the microbiome. The brand works with experts from multiple disciplines and emphasizes selected ingredients, modern manufacturing standards, and formulations without preservatives or artificial flavorings. For more information, visit inne-kids.de/en.

Disclaimer

This press release contains forward-looking statements regarding planned clinical research and future product development, which involve inherent risks and uncertainties that could cause actual outcomes to differ materially from those expressed or implied. The scientific findings referenced herein are based on preclinical animal models and should not be interpreted as evidence of health or growth-related benefits in human populations; statements regarding products containing Kidtal® or calcium have not been evaluated by regulatory health authorities and are not intended to diagnose, treat, cure, or prevent any disease.

Media Contact

Xiaolin Zheng
xlynn.zheng@moms-garden.com